PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Clinical trials for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat Heart-Lung condition
Disease control Recruiting nowThis study is testing whether adding a medication called sotatercept to standard treatments helps adults with pulmonary arterial hypertension (PAH) caused by unrepaired congenital heart defects, including Eisenmenger syndrome. About 36 adults in Japan whose PAH hasn't improved en…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Scientists seek 10,000 volunteers to unlock genetic secrets of lung pressure disease
Knowledge-focused Recruiting nowThis online research study aims to understand how genetics influence a person's risk of developing pulmonary hypertension, a condition affecting blood pressure in the lungs. The study is recruiting 10,000 adults living in the United States, and participants do not need to have a …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC